The closing price of 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) was $0.25 for the day, down -7.30% from the previous closing price of $0.26. In other words, the price has decreased by -$0.0193 from its previous closing price. On the day, 824005 shares were traded.
Ratios:
Our analysis of SXTP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.34 and its Current Ratio is at 3.58. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 31 ’24 when XU CHERYL bought 200,000 shares for $0.38 per share. The transaction valued at 75,000 led to the insider holds 424,934 shares of the business.
DOW GEOFFREY S bought 25,974 shares of SXTP for $9,740 on Jan 31 ’24. The President and CEO now owns 703,599 shares after completing the transaction at $0.38 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SXTP now has a Market Capitalization of 2.71M and an Enterprise Value of 10.54M. Its current Enterprise Value per Revenue stands at 116.18 whereas that against EBITDA is 220.16.
Stock Price History:
Over the past 52 weeks, SXTP has reached a high of $8.65, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is 0.4942, while the 200-Day Moving Average is calculated to be 0.9950.
Shares Statistics:
SXTP traded an average of 837.08K shares per day over the past three months and 243.91k shares per day over the past ten days. A total of 5.78M shares are outstanding, with a floating share count of 4.48M. Insiders hold about 22.77% of the company’s shares, while institutions hold 7.98% stake in the company. Shares short for SXTP as of Feb 29, 2024 were 151.97k with a Short Ratio of 0.18, compared to 515.73k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.37% and a Short% of Float of 1.66%.
Earnings Estimates
The firm’s stock currently is rated by 2 analysts. The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.14 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.86 and -$0.93 for the fiscal current year, implying an average EPS of -$0.89. EPS for the following year is -$0.35, with 2 analysts recommending between -$0.26 and -$0.44.
Revenue Estimates
Based on 2 analysts’ estimates, the company’s revenue will be $840k in the next fiscal year. The high estimate is $890k and the low estimate is $800k. The average revenue growth estimate for next year is up 250.00% from the average revenue estimate for this year.
